/C O R R E C T I O N -- Medline/

In the news release, Medline Launches REFLEX™ Nitinol Staple System to Enhance Surgical Patient Outcomes, issued 17-May-2021 by Medline over PR Newswire, we are advised by the company that both the first paragraph, second sentence, and the subheadline should read "FDA 510(k) Cleared" rather than "FDA-approved " as originally issued inadvertently. The complete, corrected release follows:

NORTHFIELD, Ill., May 17, 2021 /PRNewswire/ -- Attendees at this year's American College of Foot & Ankle Surgeons (ACFAS) Scientific Conference in Las Vegas will be among the first to see the Medline UNITE® REFLEX™ Nitinol Staple System (REFLEX™). This new, FDA 510(k) Cleared innovation is designed to help drive patient outcomes through improved implant strength and enhanced surgical efficiencies.

"The Medline UNITE Foot & Ankle team is laser-focused on developing specialty implant systems that enhance surgical techniques and improve patient outcomes. To help us create the new REFLEX Staple System, we leveraged expertise from several fellowship-trained foot & ankle surgeons," said Scott Goldstein, director of marketing at Medline UNITE Foot & Ankle. "The ACFAS annual scientific conference is an opportunity to interact with leading experts in the field and gain key insights that will allow us to continue developing innovations that address their unmet needs."

Several traditional staple designs used in foot and ankle surgeries are loaded onto an insertion tool to keep the staple's legs parallel, but this often becomes challenging if the bones shift just slightly. The REFLEX system improves on older designs and features an adjustable inserter that allows the surgeon to expand and contract the implant's legs for easy insertion. The staples are designed with a slightly curved bridge to provide more even compression across the fusion site.

Many staples cannot be reloaded onto conventional insertion tools and many systems do not offer a removal tool. The REFLEX system's inserter is designed with an innovative elevator-tip design that facilitates implant removal and reinsertion.

Expanding Medline's footprint in foot and ankle implant solutions
This latest innovation illustrates Medline's commitment to collaborating with leading foot and ankle surgeons to develop intelligently designed, intuitive implant systems. REFLEX is just one of a dozen new implant systems the Medline UNITE division plans to launch in 2021.

Learn more about Medline's REFLEX Nitinol Staple System at booth #302 at the conference or visit https://medlineunite.com/product/reflex-nitinol-staples/.

About Medline:

Medline is a healthcare company; a manufacturer, distributor and solutions provider focused on improving the overall operating performance of healthcare. Medline works with both the country's largest healthcare systems and independent facilities across the continuum of care to provide the clinical and supply chain resources required for long-term financial viability in delivering high quality care. With the size of one of the country's largest companies and the agility of a family-owned business, Medline is able to invest in its customers for the long-term and rapidly respond with customized solutions. Headquartered in Northfield, Ill., Medline has 27,000+ employees worldwide, a fleet of nearly 1,200 trucks and does business in more than 125 countries. Learn more about Medline at www.medline.com.

Facebook
Twitter
LinkedIn
YouTube

View original content to download multimedia:http://www.prnewswire.com/news-releases/medline-launches-reflex-nitinol-staple-system-to-enhance-surgical-patient-outcomes-301292899.html

SOURCE Medline